Aclarion, Inc. Common Stock
$2.52
-$0.12 (-4.55%)
$2.47Day Range$2.64
Key Statistics
Market Cap
$7.26M
Shares Outstanding
2.9M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Apr 22, 2022
Round Lot
100
Locale
US
Trading Data
Day Open
$2.59
Day High
$2.64
Day Low
$2.47
Volume
15.7K
VWAP
$2.55
Prev Close
$2.64
Transactions
--
Acc. Volume
--
About Aclarion, Inc. Common Stock
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.
SERVICES-MEDICAL LABORATORIESSIC 807111 employees8181 ARISTA PLACE, BROOMFIELD, CO, 80021833 275 2266IPO Apr 22, 2022US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001635077
- Composite FIGI
- BBG014FBN4K3
- Share Class FIGI
- BBG014FBN5N7
- Ticker Root
- ACON
- SIC Code
- 8071
About Aclarion, Inc. Common Stock (ACON) Stock
Aclarion, Inc. Common Stock (ACON) closed the 2026-09-18 session at $2.52, down 4.55% versus the previous close (-0.12). The stock opened at $2.59 and traded between $2.47 and $2.64 during that session. Session trading volume was 16K shares. The volume-weighted average price (VWAP) is $2.55.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.
Aclarion, Inc. Common Stock has a market capitalization of $7.3 million. The company operates in the SERVICES-MEDICAL LABORATORIES industry classification. ACON is listed on the XNAS exchange. The company employs approximately 11 people. Aclarion, Inc. Common Stock is headquartered in BROOMFIELD, CO. The recorded listing date is 2022-04-22.
On this page you can find market ACON stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SERVICES-MEDICAL LABORATORIES sector.